Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41,061,008
-
Total 13F shares
-
7,031,883
-
Share change
-
+195,753
-
Total reported value
-
$16,498,373
-
Price per share
-
$2.35
-
Number of holders
-
11
-
Value change
-
+$460,020
-
Number of buys
-
4
-
Number of sells
-
2
Institutional Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) as of Q2 2023
As of 30 Jun 2023,
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,031,883 shares.
The largest 10 holders included
22NW, LP, LVW Advisors, LLC, Nantahala Capital Management, LLC, MANGROVE PARTNERS, Praetorian PR LLC, Ikarian Capital, LLC, BOOTHBAY FUND MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Inc., and Tower Research Capital LLC (TRC).
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.